Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy
Tianyi Ma, Xiaohui Huang, Haoxiao Zheng, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Mitochondrial quality control mechanisms as molecular targets in diabetic heart
Xing Chang, Yukun Li, Chen Cai, et al.
Metabolism (2022) Vol. 137, pp. 155313-155313
Closed Access | Times Cited: 104
Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
Jin-Ling Huo, Qi Feng, Shaokang Pan, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis
Cheng Peng, Yanxiu Zhang, Xueyan Lang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 53
Quercetin inhibits necroptosis in cardiomyocytes after ischemia–reperfusion via DNA‐PKcs‐SIRT5‐orchestrated mitochondrial quality control
Xing Chang, Qin Zhang, Yu Huang, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2496-2517
Closed Access | Times Cited: 46
Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Xingyu Long, Min Liu, Yayun Nan, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 26
Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases
Poojarani Panda, Henu Kumar Verma, Saikrishna Lakkakula, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 63
PGAM5-Mediated PHB2 Dephosphorylation Contributes to Diabetic Cardiomyopathy by Disrupting Mitochondrial Quality Surveillance
Rongjun Zou, Jun Tao, Jie He, et al.
Research (2022) Vol. 2022
Open Access | Times Cited: 52
The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics
Aolin Li, Lu Lian, Xin-nong Chen, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 236-251
Closed Access | Times Cited: 34
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Yanan Cheng, Yan Wang, Ruili Yin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 24
Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies
Chen Cai, Feng Wu, Jing He, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5276-5290
Open Access | Times Cited: 34
Mitochondrial quality control in health and cardiovascular diseases
Asli E. Atici, Timothy R. Crother, Magali Noval Rivas
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 20
Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs
Yutong Zhou, Wendong Suo, Xinai Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115669-115669
Open Access | Times Cited: 17
Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment
Marianna Leopoulou, Panagiotis Theofilis, Athanasios Kordalis, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 5, pp. 512-527
Open Access | Times Cited: 16
CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction
Ping Guo, Shuiqing Hu, Xiaohui Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus
Wenwen Ding, Xiaoxue Yang, Kaiyi Lai, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 3, pp. 219-248
Closed Access | Times Cited: 5
TLR4 mediates glucolipotoxicity-induced mitochondrial dysfunction in osteoblasts by enhancing NLRP3-MAVS expression and interaction
Ximei Shen, Xiaohong Chen, Shuai Zhong, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114438-114438
Closed Access
miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1
Yinghong Zhu, Xuewen Yang, Jing Zhou, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 22
Early detection of cardiac fibrosis in diabetic mice by targeting myocardiopathy and matrix metalloproteinase 2
H Liu, Wei‐Feng Yan, Chengyong Ma, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 367-378
Open Access | Times Cited: 4
Dual-specificity phosphatase 1 interacts with prohibitin 2 to improve mitochondrial quality control against type-3 cardiorenal syndrome
Nanyang Liu, Yanqiu Ding, Hao Zhou, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 3, pp. 547-561
Open Access | Times Cited: 4
Mitochondrial Dysfunction as a Therapeutic Target in Diabetic Cardiomyopathy: Progress and Prospects
Feng Zhang, Zhuqing Li, Yanxin Wang, et al.
Cardiovascular Innovations and Applications (2025) Vol. 10, Iss. 1
Open Access
Non-coding RNA as a key regulator and novel target of apoptosis in diabetic cardiomyopathy: Current status and future prospects
Yicheng Liu, Jie Yuan, Yuhang Zhang, et al.
Cellular Signalling (2025) Vol. 128, pp. 111632-111632
Closed Access
Enhancing cardiac repair post-myocardial infarction: a study on GATM/Gel hydrogel therapeutics
Te Li, Lijuan Ding, Qiang Wang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Cardiomyocyte-specific deletion of STING improves cardiac function, glucose homeostasis, and wound healing in diabetic mice
Xiaorong Li, Kai Guo, Qingju Zhou, et al.
Life Sciences (2025), pp. 123470-123470
Closed Access
Autophagy in High-Fat Diet and Streptozotocin-Induced Metabolic Cardiomyopathy: Mechanisms and Therapeutic Implications
Rong Zhou, Zhaoming Zhang, Xinjie Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1668-1668
Open Access
Dapagliflozin improves endothelial cell dysfunction by regulating mitochondrial production via the SIRT1/PGC-1α pathway in obese mice
Lianqi He, Yanhua Li, Di Zhang, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 615, pp. 123-130
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top